COGT — Cogent Biosciences Share News
0.000.00%
Last trade - 00:00Brief: Cogent Biosciences Announces Multiple Poster Presentations At 2025 American Association For Cancer Research (AACR) Annual Meeting
U.S. RESEARCH ROUNDUP-Autodesk, Coca-Cola, NetApp
Cogent Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Cogent Biosciences Q4 Income From Operations USD -73.734 Million
U.S. RESEARCH ROUNDUP- Domino's Pizza, Honeywell, Walmart
Brief: Cogent Biosciences Updated Clinical Results From Open Label Extension Portion Of Summit Trial
U.S. RESEARCH ROUNDUP-Cisco, Freshpet, Nvidia
Cogent Biosciences Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Cogent Biosciences Q3 EPS USD -0.64
U.S. RESEARCH ROUNDUP-Costco Wholesale, McKesson, Starbucks
Brief: Cogent Biosciences Announces Phase 3 Peak Trial In Patients With Gastrointestinal Stromal Tumors Has Completed Enrollment
Cogent Biosciences Inc reports results for the quarter ended in January - Earnings Summary
Brief: Cogent Biosciences Q2 EPS USD -0.59
Cogent Biosciences Inc expected to post a loss of 56 cents a share - Earnings Preview
Brief: Cogent Biosciences Announces Positive FDA Meeting And Alignment On MS2D2
Brief: Cogent Biosciences Announces Additional Clinical Data From Part 1 Of Its Ongoing Summit Trial
Brief: Cogent Biosciences Appoints Cole Pinnow As Chief Commercial Officer
Brief: Cogent Biosciences Announces Positive Updated Lead-In Data From Ongoing Phase 3 Peak Trial Evaluating Bezuclastinib In Combination With Sunitinib In Patients With GIST
U.S. RESEARCH ROUNDUP-Deere & Co, Under Armour, Walmart